Human Milk Microbiota: Origin and Potential Uses.

Nestle Nutr Inst Workshop Ser

Department of Nutrition and Food Science, Complutense University of Madrid, Madrid, Spain,

Published: October 2021

AI Article Synopsis

  • Research at the start of the 21st century revealed that human milk has its own unique microbiota, primarily consisting of specific bacteria like Staphylococcus and Bifidobacterium.
  • The bacteria in breast milk come from various sources, including the infant's mouth and the mother's skin, as well as more complex pathways involving the mother's digestive system.
  • The human milk microbiota has potential applications for both infants and mothers, particularly in treating conditions like infectious mastitis during breastfeeding.

Article Abstract

At the beginning of the 21st century, some pioneer studies provided evidence of the existence of a site-specific human milk microbiota. Hygienically collected milk samples from healthy women contain a relatively low bacterial load, which consist mostly of Staphylococcus, Streptococcus, lactic acid bacteria, and other gram-positive bacteria (Corynebacterium, Propionibacterium, and Bifidobacterium). DNA from strict anaerobic bacteria is also detected in human milk samples. The origin of human milk bacteria still remains largely unknown. Although the infant's oral cavity and maternal skin may provide microbes to milk, selected bacteria of the maternal digestive microbiota may access the mammary glands through oral- and enteromammary pathways involving interactions with immune cells. In addition, when milk is collected using external devices, such as breast pumps, some microorganisms may arise from unhygienic handling as well as from the water used to clean and rinse the devices, for example. The human milk microbiota has a wide spectrum of potential uses. Most of them have been focused on the infant (including the preterm ones), but some bacterial strains present in human milk have also a big potential to be used to improve the mother's health, mainly through the prevention or treatment of infectious mastitis during lactation.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000505031DOI Listing

Publication Analysis

Top Keywords

human milk
24
milk microbiota
12
milk
8
milk samples
8
human
6
bacteria
5
microbiota
4
microbiota origin
4
origin potential
4
potential 21st
4

Similar Publications

We hypothesized that improving the fat globule structure of infant formulae based on the milk fat globule membrane (MFGM) would regulate metabolites and metabolic pathways, making it more similar to the metabolic properties of human milk. Therefore, we prepared infant formulae with different fat globule structures, including two model infant formulae (F1: fat globules surrounded by MFGM; F2: fat globules surrounded by protein) and one commercial infant formulae containing MFGM, and compared their metabolic differences with those of human milk. The number of differential metabolites between each sample and human milk reached 60 (F1), 132 (F2) and 126 (IF1).

View Article and Find Full Text PDF

Context: Human milk provides nutrients for newborns, while breastfeeding is preferred, formula feeding can also provide necessary nutrition and after weaning, individuals of all ages frequently drink bovine milk. Bovine and human milk contain lactose as a carbohydrate source, and infant milk formulas are also designed the same. However, lactose is fermentable by Streptococcus mutans, much like sucrose but to a lower extent.

View Article and Find Full Text PDF

Brucella spp. is the bacterium responsible for brucellosis, a zoonotic infection that affects humans. This disease poses significant health challenges and contributes to poverty, particularly in developing countries.

View Article and Find Full Text PDF

Background: The human gut microbiota develops in concordance with its host over a lifetime, resulting in age-related shifts in community structure and metabolic function. Little is known about whether these changes impact the community's response to microbiome-targeted therapeutics. Providing critical information on this subject, faecal microbiomes of subjects from six age groups, spanning from infancy to 70-year-old adults (n = six per age group) were harvested.

View Article and Find Full Text PDF

Background/objectives: This study aimed to determine the percentage and duration of neutralizing antibodies against the Omicron variant in human milk after vaccination against SARS-CoV-2, considering the three different vaccine technologies approved in Brazil.

Methods: A cross-sectional study was conducted with lactating women who received the complete vaccination cycle with available vaccines (AstraZeneca, Pfizer, CoronaVac, and Janssen). The participants resided in Rio de Janeiro, and samples were collected from April to October 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!